Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors

Brain, Behavior, and Immunity

Volumn 57, Issue , 2016, Pages 293-303

  Ramirez, Karol ^a,c   Sheridan, John F ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Anxiety like behavior; Imipramine; Microglia; Psychosocial stress; Social avoidance; Social defeat

Indexed keywords

CD11B ANTIGEN; CORTICOSTERONE; IMIPRAMINE; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; DEPRESSION; GRANULOCYTE; HEMATOPOIESIS; MALE; MONOCYTE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; SOCIAL AVOIDANCE BEHAVIOR; ANIMAL; ANXIETY; BLOOD; C57BL MOUSE; COMPLICATION; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; MENTAL STRESS; METABOLISM; MYELOID PROGENITOR CELL; PREVENTION AND CONTROL; SPLEEN;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEPRESSION; IMIPRAMINE; INFLAMMATION; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MYELOID PROGENITOR CELLS; SPLEEN; STRESS, PSYCHOLOGICAL;

EID: 84973659404     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.05.008     Document Type: Article

References (58)

1. Antonioli, M., Rybka, J., Carvalho, L.A., Neuroimmune endocrine effects of antidepressants. Neuropsychiatr. Dis. Treat. 8 (2012), 65–83.
2. Avitsur, R., Padgett, D.A., Dhabhar, F.S., Stark, J.L., Kramer, K.A., Engler, H., Sheridan, J.F., Expression of glucocorticoid resistance following social stress requires a second signal. J. Leukoc. Biol. 74:4 (2003), 507–513.
3. Avitsur, R., Stark, J.L., Sheridan, J.F., Social stress induces glucocorticoid resistance in subordinate animals. Horm. Behav. 39 (2001), 247–257.
4. Bailey, M.T., Kierstein, S., Sharma, S., Spaits, M., Kinsey, S.G., Tliba, O., Amrani, Y., Sheridan, J.F., Panettieri, R.A., Haczku, A., Social stress enhances allergen-induced airway inflammation in mice and inhibits corticosteroid responsiveness of cytokine production. J. Immunol. 182:12 (2009), 7888–7896.
5. Basterzi, A.D., Aydemir, C., Kisa, C., et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum. Psychopharmacol. 20 (2005), 473–476.
6. Bondesson, L., Nordlind, K., Liden, S., Sundstrom, E., Inhibiting effects of serotonin and serotonin antagonists on the migration of mononuclear leucocytes. Immunopharmacol. Immunotoxicol. 15 (1993), 243–250.
7. Brustolim, D., Ribeiro-dos-Santos, R., Kast, R.E., Altschuler, E.L., Soares, M.B., A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int. Immunopharmacol. 6 (2006), 903–907.
8. Castanon, N., Leonard, B., Neveu, P., Yirmiya, R., Effects of antidepressants on cytokine production and actions. Brain Behav. Immun. 16:5 (2002), 569–574.
9. Engler, H., Bailey, M.T., Engler, A., Sheridan, J.F., Effects of repeated social stress on leukocyte distribution in bone marrow, peripheral blood and spleen. J. Neuroimmunol. 148:1–2 (2004), 1–2.
10. Engler, H., Engler, A., Bailey, M.T., Sheridan, J.F., Tissue-specific alterations in the glucocorticoid sensitivity of immune cells following repeated social defeat in mice. J. Neuroimmunol. 163:1–2 (2005), 1–2.
11. Eshleman, A.J., Carmolli, M., Cumbay, M., Martens, C.R., Neve, K.A., Janowsky, A., Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J. Pharmacol. Exp. Ther. 289:2 (1999), 877–885.
12. Frank, Matthew G., Wieseler-Frank, Julie L., Watkins, Linda R., Maier, Steven F., Rapid isolation of highly enriched and quiescent microglia from adult rat hippocampus: Immunophenotypic and functional characteristics. J. Neurosci. Methods 151:2 (2006), 121–130.
13. Frommberger, U.H., Bauer, J., Haselbauer, P., Fraulin, A., Riemann, D., Berger, M., Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 247 (1997), 228–233.
14. Gandolfi, O., Barbaccia, M.L., Costa, E., Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors. J. Pharmacol. Exp. Ther. 229:3 (1984 Jun), 782–786.
15. Ghorbel, M.T., Sharman, G., Leroux, M., Barrett, T., Donovan, D.M., Becker, K.G., Murphy, D., Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J. Biol. Chem. 278:21 (2003), 19280–19285.
16. Glowinski, J., Axelrod, J., Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 204 (1964), 1318–1319.
17. Goshen, I., Yirmiya, R., Interleukin-1 (IL-1): A central regulator of stress responses. Front. Neuroendocrinol. 30:1 (2009), 30–45.
18. Hanke, M.L., Powell, N.D., Stiner, L.M., Bailey, M.T., Sheridan, J.F., Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress. Brain Behav. Immun. 26:7 (2012), 1150–1159.
19. Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P.L., Kanba, S., Antidepressants inhibit interferon-@c-induced microglial production of IL-6 and nitric oxide. Exp. Neurol. 206:1 (2007), 33–42.
20. Henry, C.J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M.T., Sheridan, J.F., Godbout, J.P., Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflamm., 5, 2008, 15.
21. Henry, C.J., Huang, Y., Wynne, A.M., Godbout, J.P., Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 23:3 (2009), 309–317.
22. Hwang, J., Zheng, L.T., Ock, J., Lee, M.G., Kim, S.H., Lee, H.W., Lee, W.H., Park, H.C., Suk, K., Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 55:5 (2008), 826–834.
23. Idova, G.V., Cheido, M.A., Stimulation of the immune response during blockade of serotonin receptors by cyproheptadine. Biull. Eksp. Biol. Med. 103 (1987), 440–442.
24. Iversen, L., Neurotransmitter transporters and their impact on the development of psychopharmacology. Br. J. Pharmacol. 147:Suppl 1 (2006), S82–S88.
25. Jankord, R., Turk, J.R., Schadt, J.C., Casati, J., Ganjam, V.K., Price, E.M., Keisler, D.H., Laughlin, M.H., Sex difference in link between interleukin-6 and stress. Endocrinology 148:8 (2007), 3758–3764.
26. Jankord, R., Zhang, R., Flak, J.N., Solomon, M.B., Albertz, J., Herman, J.P., Stress activation of IL-6 neurons in the hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299:1 (2010), 343–351.
27. Johnson, J.D., Campisi, J., Sharkey, C.M., Kennedy, S.L., Nickerson, M., Greenwood, B.N., Fleshner, M., Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135:4 (2005), 1295–1307.
28. Kast, R.E., Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels. Gen. Hosp. Psychiatry 25 (2003), 495–496.
29. Kinsey, S.G., Bailey, M.T., Sheridan, J.F., Padgett, D.A., Avitsur, R., Repeated social defeat causes increased anxiety-like behavior and alters splenocyte function in C57BL/6 and CD-1 mice. Brain Behav. Immun. 21:4 (2007), 458–466.
30. Klimek, V., Stockmeier, C., Overholser, J., Meltzer, H.Y., Kalka, S., Dilley, G., Ordway, G.A., Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J. Neurosci. 17:21 (1997 Nov 1), 8451–8458.
31. Kubera, M., Holan, V., Mathison, R., Maes, M., The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology 25:8 (2000), 785–797.
32. Lim, C.M., Kim, S.W., Park, J.Y., Kim, C., Yoon, S.H., Lee, J.K., Fluoxetine affords robust neuroprotection in the post-ischemic brain via its anti-inflammatory effect. J. Neurosci. Res. 87:4 (2009), 1037–1045.
33. Maes, M., The immunoregulatory effects of antidepressants. Hum. Psychopharmacol. 16:1 (2001), 95–103.
34. Michelson, D., Galliven, E., Hill, L., Demitrack, M., Chrousos, G., Gold, P., Chronic imipramine is associated with diminished hypothalamic–pituitary–adrenal axis responsivity in healthy humans. J. Clin. Endocrinol. Metabol. 82:8 (1997), 2601–2606.
35. Miller, A.H., Haroon, E., Raison, C.L., Felger, J.C., Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 30:4 (2013), 297–306.
36. Morikawa, O., Sakai, N., Obara, H., Saito, N., Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur. J. Pharmacol. 349 (1998), 317–324.
37. Mossner, R., Heils, A., Stober, G., Okladnova, O., Daniel, S., Lesch, K.P., Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem. Int. 33 (1998), 251–254.
38. Nair, A., Bonneau, R.H., Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J. Neuroimmunol. 171:1–2 (2006), 72–85.
39. + T cell activation during the development of stress-induced herpes simplex virus type-1 encephalitis. Brain Behav. Immun. 21:6 (2007), 791–806.
40. Nordlind, K., Sundstrom, E., Bondesson, L., Inhibiting effects of serotonin antagonists on the proliferation of mercuric chloride stimulated human peripheral blood T lymphocytes. Int. Arch. Allergy Immunol. 97 (1992), 105–108.
41. Powell, N.D., Tarr, A.J., Sheridan, J.F., Psychosocial stress and inflammation in cancer. Brain Behav. Immun. 30 (2013), 41–47.
42. Ramamoorthy, S., Ramamoorthy, J.D., Prasad, P.D., Bhat, G.K., Mahesh, V.B., Leibach, F.H., Ganapathy, V., Regulation of the human serotonin transporter by interleukin-1 beta. Biochem. Biophys. Res. Commun. 216 (1995), 560–567.
43. Ramirez, K.G., Shea, D.T., McKim, D.B., Reader, B.F., Sheridan, J.F., Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance. Brain Behav. Immun. 46 (2015), 212–220.
44. Russo, S.J., Nestler, E.J., The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 14:9 (2013), 609–625.
45. Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., Kirchner, H., Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr. Scand. 94:3 (1996), 198–204.
46. Sluzewska, A., Rybakowski, J., Laciak, M., Mackiewicz, A., Sobieska, M., Wiktorowicv, K., Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. NY Acad. Sci. 762:1 (1995), 474–476.
47. Smejkal-Jagar, L., Boranic, M., Serotonin, serotonergic agents and their antagonists suppress humoral immune reaction in vitro. Res. Exp. Med. 194 (1994), 297–304.
48. Stark, J.L., Avitsur, R., Padgett, D.A., Campbell, K.A., Beck, F.M., Sheridan, J.F., Social stress induces glucocorticoid resistance in macrophages. Am. J. Physiol. Regul. Integr. Comp. Physiol., 49(6), 2001.
49. Stark, J.L., Avitsur, R., Hunzeker, J., Padgett, D.A., Sheridan, J.F., Interleukin-6 and the development of social disruption-induced glucocorticoid resistance. J. Neuroimmunol. 124:1–2 (2002), 1–2.
50. Wohleb, E.S., Hanke, M.L., Corona, A.W., Powell, N.D., Stiner, L.M., Bailey, M.T., Nelson, R.J., Godbout, J.P., Sheridan, J.F., β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by social defeat. J. Neurosci. 31:17 (2011), 6277–6288.
51. Wohleb, E.S., Powell, N.D., Godbout, J.P., Sheridan, J.F., Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J. Neurosci. 33:34 (2013), 13820–13833.
52. Wohleb, E.S., McKim, D.B., Sheridan, J.F., Godbout, J.P., Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front. Neurosci., 8, 2014, 447.
53. Wynne, A.M., Henry, C.J., Huang, Y., Cleland, A., Godbout, J.P., Protracted downregulation of CX 3CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav. Immun. 24:7 (2010), 1190–1201.
54. Xia, Z., DePierre, J.W., Nassberger, L., Tricyclic antidepressants inhibit IL-6, IL-1b and TNF-a release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology, 34(2–3), 1996, 27.
55. Yirmiya, R., Pollak, Y., Barak, O., Avitsur, R., Ovadia, H., Bette, M., Weihe, E., Weidenfeld, J., Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacol. 24:5 (2001), 531–544.
56. Young, M.R., Matthews, J.P., Serotonin regulation of T cell subpopulations and of macrophage accessory function. Immunology 84 (1995), 148–152.
57. Zhou, D., Kusnecov, A.W., Shurin, M.R., DePaoli, M., Rabin, B.S., Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133:6 (1993), 2523–2530.
58. Zhou, Z., Zhen, J., Karpowich, N.K., Goetz, R.M., Law, C.J., Reith, M.E., Wang, D.N., LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317:5843 (2007 Sep. 7), 1390–1393.